| 000 | 01748 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514023736.0 | ||
| 264 | 0 | _c20020322 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a1398-2273 | ||
| 024 | 7 |
_a10.1034/j.1399-3062.2001.30405.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTsoulfas, G | |
| 245 | 0 | 0 |
_aNF-kappaB in transplantation: friend or foe? _h[electronic resource] |
| 260 |
_bTransplant infectious disease : an official journal of the Transplantation Society _cDec 2001 |
||
| 300 |
_a212-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 |
_aAdenoviridae _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacology |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 |
_aGraft Rejection _xmetabolism |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xsurgery |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNF-kappa B _xphysiology |
| 650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xbiosynthesis |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type II |
| 650 | 0 | 4 |
_aOligodeoxyribonucleotides _xgenetics |
| 650 | 0 | 4 |
_aOrgan Transplantation _xphysiology |
| 650 | 0 | 4 |
_aReperfusion Injury _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xphysiology |
| 650 | 0 | 4 |
_aSulfasalazine _xpharmacology |
| 650 | 0 | 4 |
_aTacrolimus _xpharmacology |
| 700 | 1 | _aGeller, D A | |
| 773 | 0 |
_tTransplant infectious disease : an official journal of the Transplantation Society _gvol. 3 _gno. 4 _gp. 212-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1034/j.1399-3062.2001.30405.x _zAvailable from publisher's website |
| 999 |
_c11752856 _d11752856 |
||